INGRID LEON: Open Payments
NPI 1063964559 · EAST GREENWICH, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 83 payments from 15 companies in 2025. Trend: 2023 $419 · 2024 $490 · 2025 $2,075
Food & beverage: $2,075
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $575 |
| GlaxoSmithKline, LLC. | 20 | $510 |
| Regeneron Healthcare Solutions, Inc. | 11 | $286 |
| GENZYME CORPORATION | 6 | $151 |
| Verona Pharma, Inc. | 6 | $137 |
| Amgen Inc. | 3 | $76 |
| Viatris Specialty LLC | 3 | $73 |
| United Therapeutics Corporation | 3 | $63 |
| Grifols USA, LLC | 2 | $62 |
| Insmed, Inc. | 2 | $38 |
Products named: DUPIXENT, NUCALA, FASENRA, TEZSPIRE, Ohtuvayre, BREZTRI, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across RI — which companies pay providers there.
